OR WAIT null SECS
December 11, 2024
The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.
June 13, 2024
Syngene's new production platform offers rapid protein synthesis with lower risk.
January 22, 2024
Abzena has launched its AbZelect platforms, designed for improving cell line development.
August 04, 2023
Under a manufacturing agreement, Northway Biotech will develop a manufacturing process for iTolerance’s fusion protein in development for regenerative therapy.
May 09, 2022
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.
October 04, 2021
Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.
March 15, 2021
WuXi will produce SARS-CoV-2 s-proteins for BioVaxys’ COVID-19 vaccine candidate, BVX-0320, and for its Covid-T immunodiagnostic program.
February 17, 2021
The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.
December 02, 2020
The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.
October 11, 2018
The new facility will include comprehensive mammalian process development and manufacturing capabilities.